InvestorsHub Logo
Followers 14
Posts 603
Boards Moderated 0
Alias Born 12/27/2017

Re: Hugon post# 373175

Sunday, 09/05/2021 3:19:57 PM

Sunday, September 05, 2021 3:19:57 PM

Post# of 403545
That was the amount I was quoted for the tox work alone. Additionally, there's a reformulation needed, which would require another P1, so the overall expense is greater, but to complete the tox work first is a requirement.

That was a figure given to me from Leo a year or so ago when I enquired directly and was attempting to connect him with less toxic financing to advance things more rapidly.

I asked for an NDA at the time and wanted one for some PE interested parties, and he refused. I wonder why you wouldn't want more help to progress your drugs and clean up your financing?

I have some ideas now...

I don’t know about Kevetrin needing $500k to advance that drug, but if that’s true I’m utterly disgusted. I invested first because of Kevetrin and the oncology space and if it’s true they need $500k to advance that drugs, and as Lemoncat said “we have $10-15m in the bank” then there is some absolutely horrible things going on. Kevetrin shelved for three years, and the CEO’s annual salary given what you suggested (no clue if it’s true!) but if the ceo deferred his salary Kevetrin would have been unfrozen or could have been…a long time ago, let alone advanced years ago.

Why do they even have Kevetrin listed on their website at this point?!?!??

I’m just disgusted by gross mismanagement with no regard to shareholder and especially OLD shareholders. It’s like they think they are great because they are serving those who arrived at .10.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News